Search

Copyright of Turkiye Klinikleri Archives of Lung is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Purpose: Lung cancer is one of the most common cancers worldwide and smoking plays an important role in the development of lung cancer. The study aims to determine the impact of a lung cancer diagnosis on the period of smoking habits. Also, we aimed to find out the factors affecting smoking cessation in patients after being diagnosed with lung cancer. Materials and Methods: Our study is a descriptive study with 410 patients diagnosed with lung cancer and who had a history of smoking in a training and research hospital in Izmir between April and December 2018. The socio-demographic characteristics of the patients, smoking history, smoking status after the diagnosis, the duration of smoking cessation after the diagnosis, the relationship between smoking and lung cancer disease were investigated. Results: The mean age of the participants was 60.41±14.85 and 62.7% of the patients were male. Quitting smoking rate was significantly increased and the number of cigarettes smoked daily was decreased after the diagnosis of lung cancer. The rate of quitting smoking after the diagnosis was higher in male patients compared to female patients and the smoking cessation rate was found to be higher in employees. The smoking cessation rate of those who do not use alcohol is significantly higher. The smoking cessation rate was higher in the first year after the diagnosis of lung cancer. Conclusions: This study showed that the majority of the patients had quit smoking after the diagnosis of lung cancer.

Copyright of Journal of Academic Value Studies is the property of Asos Egitim Bilisim Danismanlik and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Cukurova Medical Journal / Çukurova Üniversitesi Tip Fakültesi Dergisi is the property of Cukurova University, Faculty of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: Smoking is the most common cause of preventable death and disease. Our country is one of the European countries with a high smoking rate. With the effect of social awareness, education and social situations, applications to smoking cessation outpatient clinics are increasing. In this study, we aimed to discuss both smoking cessation in our outpatient clinic and the effect of a standard 12-week varenicline regimen for smoking cessation and a standard 10-week transdermal nicotine replacement therapy (NRT) regimen on cessation. Materials and Methods: 845 patients who applied to smoking cessation clinic between January 2015 andJanuary 2018 were started retrospectively. Results: The patients included in the study were compared according to their smoking cessation status. There was no statistically significant difference between the two groups in terms of age and gender (p=0.622, p=0.241). While the Fagerstrom Nicotine Dependence Score (FNBS) was 6.12±0.9 in the group who quit smoking, it was 8.45±1.1 in the group who did not quit smoking, and there was a statistically significant difference between the groups (p=0.04). 80.5% of the patients used varenicline, 19.5% of them used nicotine patch. The patients were compared according to the drug they took. There was no statistically significant difference between Varenicline and nicotine patch in smoking cessation (p=0.707). In addition, the two groups were compared in terms of age and gender. While there was a significant difference between the two groups in terms of age (p<0.001), there was no significant difference in terms of gender (p=0.405). While FNBS was 6.95±0.9 in the varenicline group, it was 7.01±0,7 in the NRT group, and there was no significant difference between the two groups (p=0.506). Conclusions: It was observed that demographic characteristics such as age and gender did not affect smoking cessation, but low FNBS was effective in quitting smoking. In addition, it was determined that there was no difference between drugs in smoking cessation. [ABSTRACT FROM AUTHOR]

Objective: The aim of this study is to examine the changes in characteristics of smoking habits during the pandemic period. Methods: This study was conducted on the patients who admitted to Düzce University Medical Faculty Smoking Cessation Outpatient Clinic between June 2020 and January 2021 and a control group with similar age, gender, and educational background characteristics. Results: The study group with 165 patients who quit smoking during the pandemic period and the control group with 163 patients were included in the study. It was detected that patients who quit smoking during the pandemic period had attempted to quit smoking significantly less compared to those who continue smoking (p <0.04). The fagerström cigarette addiction scale scores of the patients who quit smoking during the pandemic period were found to be significantly lower than the patients who continued to smoke (p <0.001). A significant difference was found between patients who quit smoking during the pandemic period and patients who continued to smoke, in terms of psychological resilience scale total score and all subgroups (p <0.001). Conclusions: The results of our study show that the rate of efforts to quit smoking increased during the pandemic period, because smokers were affected by the negative relationship between COVID-19 and smoking, and more cessation behavior. We suggest that every patient who admitted to health institutions should be questioned in terms of smoking behavior and the psychological resilience of the patients should be evaluated. [ABSTRACT FROM AUTHOR]

Aim: To determine the attitudes of child and adolescent psychiatrists working in different institutions throughout Turkey towards smoking addiction and intervention steps. Material and Methods: An information form assessing physicians' 5As approach was established considering the studies included in the literature, and this form was applied to physicians working in the area of child psychiatry by way of e-mail and phone. Results: Although most physicians (52.5%) asked about smoking status, which is included in the first step in the 5As approach used in smoking cessation, it was observed that they implemented further steps of the 5As with gradually decreasing rates in our study. Only 15% of the physicians performed follow-up in smoking cessation treatment. Conclusion: Physicians who work with pediatric and adolescent patients in Turkey have low levels of awareness about smoking addiction and they do not feel competent. Considering that tobacco and related addictions are gradually increasing in children and adolescents, physicians must receive training in the area of smoking cessation methods and start practicing these methods. It was thought that organizing smoking cessation training for physicians would contribute positively to the treatment of patients. [ABSTRACT FROM AUTHOR]

Introduction: Cigarette smoking is one of the most important preventable risk factors for atherosclerotic diseases. This study aims to assess the smoking behaviour after acute coronary syndrome (ACS) and aims to delineate the factors affecting smoking status after discharge. Methods: The Fagerström Test for Nicotine Dependence score, the sociodemographic status of patients, types of ACS and applied treatment methods were recorded. The Gensini scoring system was used to evaluate the extent and severity of coronary artery disease. Patients were reached via phone calls in the first, third and sixth month after discharge to assess their smoking status, their reasons for relapse and any recurrences of their diseases. Results: Forty-five percent of patients were treated for ST-elevated myocardial infarction, and 43.2% (n=48) had high or very high levels of dependence. Patients who had early symptoms had a higher rate of quitting smoking (p=0.009). Only 78.4% had thought of quitting smoking after discharge. Seventy-four (66.6%) patients underwent catheter-based interventions. The rates of relapse were 20.8% (n=15), 42.6% (n=32) and 53.9% (n=41) at the end of the first, third and sixth month after discharge, respectively. Gensini scores seemed to be higher among patients who had quit smoking (p<0.05). Patients who have received medical treatment had a higher rate of smoking than before the end of six months (p<0.05). Only 28.8% (n=32) of patients stated that they had received information about smoking cessation from their famil physician and 3.6% (n=4) of patients have applied to a smoking cessation unit. Conclusion: Smoking cessation rates of patients who have suffered an ACS were low and rates of cigarette consumption in the following periods tended to increase. Family physicians should take a more active role in this topic in Turkey. [ABSTRACT FROM AUTHOR]

Objective: The aim of this study was to evaluate the results of the intervention with the "Motivational Interview" on changing the smoking behavior of adolescents in the "Adolescent Outpatient Clinic". Material and Methods: Thirty-two adolescents smoking at least three cigarettes per/day for the last three months were included in the study. The adolescents were interviewed twice with a one-week interval and then with two weeks interval. The motivational interview was conducted to help them quit smoking each time they came to interview. The adolescents were called by telephone three months after the last interview and were questioned on their smoking behavior change (how many cigarettes smoke per day). Results: The mean age of the adolescents was 16.4 ± 1.0 (min: 12.0-max: 18.0) years and 47% (n = 15) of them were female. Among adolescents 28% (n = 9) had a chronic disease. According to the statements of the adolescents three months after the last interview, 6.2% (n = 2) of adolescents quit smoking, and 50% (n = 16) decreased the amount of cigartttes smoked. A statistically significant association was found between the rate of quitting or reducing smoking and the frequency of smoking cessation intervention visits (p = 0.016) and the number of cigarettes smoked per day at first admission (p = 0.047). No significant association was found between the smoking reduction rates and the age of adolescents, the age of first experimentation, and the duration of smoking. Smoking reduction rate was found to be higher in patients with a chronic disease, a non-smoker family, female gender and regular attendance to school; but the difference was not statistically significant (p> 0.05). Conclusion: This study demonstrates that smoking intervention in the early period of smoking and the compliance to smoking cessation interventions may change the smoking behavior of adolescents. [ABSTRACT FROM AUTHOR]

The aim of this study was to investigate the relationship between weight and body mass index (BMI) changes in smokers during 1 year. Between June 1, 2012 and June 1, 2013, 460 individuals who applied to Ondokuz Mayıs University Faculty of Medicine Family Medicine Smoking Cessation Policlinic were interviewed by telephone, and a structured interview was conducted. Participants were asked about their current smoking status and weight. Exercise and diet suggestions were scored on a 5-point Likert-type scale to determine how well participants followed the suggestions. The data obtained were compared with anthropometric data from the patient's first visit to the outpatient clinic. Demographic data, social data, and smoking characteristics of the subjects (pack/year, Fagerstrom Nicotine Dependence Test [FNDT] scores) were examined with weight changes as independent variables. Overall, 100 cases (21.7%) did not smoke after one year, and 145 recurrent cases (31.7%) did not smoke for a mean of 4.21±4.14 months. Women who quit smoking were more likely to comply with exercise recommendations than others (F=2.875, p=0.015). Women who quit smoking gained 3.77±2.6 kg and their BMI increased by 1.33±1.9 kg/m2. Men who quit smoking gained 5.03±3.2 kg in one year, and their BMI increased by 1.52±1.7 kg/m2. It was observed that men who quit smoking gained more weight than women did (F=2.102, p<0.001). Our subjects gained weight within a year after quitting smoking. Detailed studies are needed to investigate weight gain after smoking cessation. [ABSTRACT FROM AUTHOR]

The population of this study, which was conducted with people who applied to a smoking cessation clinic, consisted of the individuals who applied to Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital Smoking Cessation Clinic for smoking cessation. The sample of the study consisted of 126 individuals. In the study, an information form was used to obtain data from the sample. SPSS 23 packaged software was used to analyze the data, and nonparametric tests were preferred for data analysis. The number of factors that cause smoking cessation is more than twice the number of factors that cause smoking initiation. It was determined that health and economic reasons were effective among the reasons for smoking cessation, and being unable to cope with enthusiasm, curiosity, and stress were the most important reasons for smoking initiation. The desire of smokers to smoke is increasing, especially after meals, under stress, and while drinking tea or coffee. Even if individuals quit smoking, the success of smoking cessation decreases over time. [ABSTRACT FROM AUTHOR]

Cigarette smoking is estimated to increase to eight million deaths due to smoking in the world by 2030 when it is estimated that the current trends continue. E-cigarettes are encouraged products as an alternative to help reduce or completely quit the use of conventional cigarettes; however, the extent to which it affects smoking cessation has not yet been clearly established. E-cigarettes mimic the conventional form of smoking because they are consumed by inhalation, although they do not contain tobacco and combustion processes. In the studies, E-cigarette users; it is reported that they prefer E-cigarettes because they help to quit conventional cigarettes, reduce the consumption and cost of conditional cigarettes, use it in places where smoking is prohibited and be less harmful than conditional cigarettes. In E-cigarettes, there are various amounts of chemical agents in liquids used to generate steam, and manufacturers do not have sufficient knowledge of the interaction and safety of these chemicals. It was determined that the vegetable glycerin and propylene glycerol in E-cigarettes were degraded at high temperatures. With the breathing of the user, the liquid composition in the E-cigarette vaporizes by heating. This heating phase can turn into toxic components in the inhalation of E-cigarette vapor by causing physical changes and chemical reactions. The role of E-cigarettes in smoking cessation due to its health effects and yet unknown aspects is one of the topics frequently discussed by experts. Due to the widespread use of E-cigarettes, the latest form of new generation tobacco use both in our country and in the world, it is necessary to increase awareness and knowledge of nurses on this issue and in addition to have sufficient information about the usage results of E-cigarettes in quitting conventional cigarettes. [ABSTRACT FROM AUTHOR]

Objectives: The presence of psychiatric disorder is not obstacle for the treatment to quit smoking; however this treatment is not preferred among primary purposes in these patients. We aimed to investigate use of tobacco, whether asked their smoking habit by a psychiatrist, the request of patients who smoke to quit smoking, whether they can get help from the psychiatric outpatient clinic of knowledge about smoking cessation and "Addiction and Treatment of Smoking" training of the psychiatrists effects on query of smoking status. Methods: This study was conducted at Outpatient Clinic of the Beyhekim Department of Psychiatry at Konya Education and Research Hospital between June and July 2013. Five-item questionnaire was administered to all participants after the examination in the first phase.. The outpatient clinic doctors were not informed about the questionnaire during examination because of alteration their interrogation of smoking. In September 2013, "Addiction and Treatment of Smoking" training were given to the psychiatrists doctors working in this study. In the second phase of this study, same questionnaire was administrated to patients of these trained doctors.. Results: 51.1% of participants were smokers. In the first phase of the study, doctors from the 18.3% (n= 40) and 53.5% (n = 95) in the second phase had questioned smoking of patients. After training seminar the rate to question of doctors had significantly increased (p<0.001). %37.9 of participants (n=69) wanted to quit smoking. %46.9 of participants (n=186) knew that they can get help from the psychiatric outpatient clinic for smoking cessation. Conclusion: "Chance to get rid of smoking addiction" should be offered to patients in psychiatric outpatient clinics. Working to increase the knowledge of psychiatrics on this subject should be made. [ABSTRACT FROM AUTHOR]

Amaç: Bu çalışmada bir sigara bırakma polikliniğinin ilk verilerinin değerlendirilmesi amaçlanmıştır. Yöntem:; 2009-2010 yılları arasında Konya Numune hastanesinde sigara bıraktırma polikliniğine, sigarayı kendi kendine bıraktıktan sonra sigara içiciliğine yeniden başlamamak için yardım isteyen 8 kadın, 17 erkekten oluşan toplam 25 sigara içicisinin bir yıllık takip sonuçları retrospektif olarak değerlendirilmiştir. Bulgular: 25 olgunun ilk bir ay içerisinde yardım istediği belirlenmiştir. Sigara bırakımı akabinde bu olgularda sıklık sırasına göre aşırı sinirlilik, oral aft, kabızlık, kilo alma yakınmalarının ortay a çıktığı bildirilmiştir. Hiçbir olguya nikotin yerine koyma tedavisi verilmemiş ve 20 olguya serotonin geri alım inhibitörü başlanmıştır. Bir yıllık takip periyodunda olgulardan 9’u yeniden sigara içmeye başlarken, 16’sında sigara bırakmışlığın devamlılığı sağlanabilmiştir. Sonuç: Kendi kendine sigarayı bırakan kişilerin yeniden sigara içmemek için yardım istediğinde, erken dönemde kendilerine yapılan motivasyonel ve/veya farmakoterapi, sigara bırakmışlığın süregenliğinde büyük önem taşımaktadır.

Smoking is still the most important cause of preventable diseases and premature deaths. Thus, smoking cessation interventions should include pharmacological therapies and/or counseling either alone or in combination. To analyze the demographic data of patients who presented to the smoking cessation polyclinic and received pharmacological therapies and determine the success rate of given therapies, and the factors that affect smoking cessation rates retrospectively. This retrospective study included patients who presented to the smoking cessation polyclinic and received pharmacological therapy (varenicline, bupropion or nicotine replacement therapy). Demographic data of patients, exhaled carbonmonoxide levels, and Fagerström test for nicotine addiction results were derived. Patients were reached by telephone survey in February 2013, and asked for their current smoking status and duration of therapy at the end of therapy. Patients were grouped into quitters and non-quitters. Differences between groups were assessed, and success rates of pharmacological therapies were compared. The study included 240 women and 509 men. Fagerström test for nicotine addiction results and exhaled carbonmonoxide levels were statistically higher in the non-quitter group than the quitter group. We did not find any significant difference between the groups in variables such as profession, age, gender, marital status and education levels. Varenicline had the highest smoking cessation rates at the end of therapy, and the rates were significantly different from others. Smoking cessation rates for varenicline, bupropion and nicotine replacement therapy were 50.9%, 35.9%, and 35.2%, respectively (p<0,05). However, long-term success rates (3-12 months) were similar for all pharmacotherapies. Long-term success rates of pharmacological interventions used for smoking cessation were not significantly different among groups. To prevent relapses, patients should be monitorized closely and new interventions should be developed to keep patients' motivation high for long-term abstinence. [ABSTRACT FROM AUTHOR]

Copyright of Turkiye Klinikleri Archives of Lung is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: Smoking is an important contributor to respiratory diseases and is the major etiological factor for the development of chronic obstructive pulmonary disease (COPD) and adversely affects control of asthma. For this reason, smoking cessation is the one of the most important ways to improve the prognosis of patients with respiratory disease. Our aim was to determine the characteristics with the long-term smoking cessation rates of outpatients with COPD and asthma and compared the differences between the diseases. Material and Method: 42 smokers with COPD and 28 asthma patients were prospectively evaluated in 2007. All of the patients answered the Fagerstrom test with a regular questionnaire of general characteristics. Baseline spirometry and CO oximetry were performed. The 24 months follow-up results and demographic characteristics were reported. Results: COPD patients were older and the total amount of smoked cigarettes was higher with an evident airway obstruction. In the first year, the smoking cessation rate was less with high tobacco dependence relapses in outpatients with asthma (32% and 18%) compared with COPD (55% and 9%). Asthma patients were predominantly women and cessation rates were quite low with higher relapse rates in women compared with men. At the end of 2 years follow up, smoking cessation rates for COPD was 45%, whereas this was 18% for asthma, which was dramatically low. Conclusion: Results of this analysis confirm that smoking cessation is still a huge problem to be solved in respiratory diseases. Even if smoking is not an etiological factor in asthma, tobacco dependence is more severe and long-term cessation rates are very low with high relapses. [ABSTRACT FROM AUTHOR]

Smoking which is estimated to have caused around 4.2 million deaths in a year, is an important public health problem all around the world. The smoking cessation rates 80% at beginning and it's decrease to 15-29% at the end of first year with in smoking cessation clinic and tobacco control methods. In this study we aimed to determinate that the risk factors for relaps after smoking cessation at first admission to smoking cessation clinic. Material and Methods: We examine that the relationship between demographic properties and factors affecting restarted smoking (relaps) in 707 patients who admitted to smoking cessation clinic in Chest Diseases and Thoracic Surgery Hospital between 2004-2006. Results: 454 patients (64.2%) were quitted smoking, 253 patients (35.8%) couldn't quit smoking. 152 (%33.5) of 454 patients who were quitted smoking in this series, restarted smoking (relaps) again. There were relations between relaps and female sex, the Fagerstrom Test for Nicotine Dependence (FTND) score, subject who wanted to use nicotine replasman therapy (p< 0.05). There were no affect between relaps and age, initial age, regular smoking age, marital status, duration of smoking, number of daily cigarette, education level, any smoker in the family (p> 0.05). Conclusion: We suggest that to determinate that the risk factors for relaps after smoking cessation is more help full for to struggle with smoking at first admission to smoking cessation clinics. [ABSTRACT FROM AUTHOR]

To assess the impact of a diagnosis of bladder cancer on smoking behavior and to analyze the role of the physician in smoking cessation. Nonmuscle-invasive bladder cancer patients completed a phone survey of their smoking habits. They were asked about smoking behavior before and after the diagnosis of cancer and whether they had been informed by their physician about the relation between smoking and bladder cancer . Two hundred-twelve patients responded to the survey. The mean age was 60.03±6.36 years. Ninety-three of the 135 current smokers (68.9%) were advised to quit smoking, whereas nine of 20 nonsmokers (45%) were not commented about the future risks of smoking. The results showed that 13% of the current smokers and 35% of the current nonsmokers were not warned about the relation of bladder cancer with smoking. Statistical significance was not seen in terms of sex, disease stage, and tumor grade at diagnosis. The relation between smoking and bladder cancer has been well established. However, some patients are not informed to quit smoking by their physicians. [ABSTRACT FROM AUTHOR]